Picture of ProQR Therapeutics NV logo

PRQR — ProQR Therapeutics NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

ProQR Therapeutics NV reports results for the quarter ended in June - Earnings Summary

* ProQR Therapeutics NV  PRQR.OQ  reported a quarterly
adjusted
loss of 3 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -10 cents.  The mean expectation of six analysts
for the quarter was for a loss of 12 cents per share. Wall
Street expected results to range from -17 cents to -8 cents per
share.
    * Revenue rose 407.6% to $6.31 million from a year ago;
analysts
expected €11.46 million. 
    * ProQR Therapeutics NV's reported EPS for the quarter was a
loss
of 3 cents​.
    * The company reported a quarterly loss of €2.69 million.
    * ProQR Therapeutics NV shares had risen by 10.2% this
quarter and
lost 7.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 9.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for ProQR
Therapeutics NV is $5.00 
This summary was machine generated from LSEG data August 8 at
03:49 p.m. UTC. ​All figures in euros unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.12          -0.03          Beat
 Mar. 31 2024      -0.11          -0.09          Beat
 Dec. 31 2023      0.01           -0.07          Missed
 Sep. 30 2023      -0.09          -0.07          Beat

Recent news on ProQR Therapeutics NV

See all news